Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lipodystrophic syndromes due to LMNA mutations: recent developments on biomolecular aspects, pathophysiological hypotheses and therapeutic perspectives.
Vigouroux C, Guénantin AC, Vatier C, Capel E, Le Dour C, Afonso P, Bidault G, Béréziat V, Lascols O, Capeau J, Briand N, Jéru I. Vigouroux C, et al. Among authors: bereziat v. Nucleus. 2018 Jan 1;9(1):235-248. doi: 10.1080/19491034.2018.1456217. Nucleus. 2018. PMID: 29578370 Free PMC article. Review.
Type A insulin resistance syndrome revealing a novel lamin A mutation.
Young J, Morbois-Trabut L, Couzinet B, Lascols O, Dion E, Béréziat V, Fève B, Richard I, Capeau J, Chanson P, Vigouroux C. Young J, et al. Among authors: bereziat v. Diabetes. 2005 Jun;54(6):1873-8. doi: 10.2337/diabetes.54.6.1873. Diabetes. 2005. PMID: 15919811
Diseases of adipose tissue: genetic and acquired lipodystrophies.
Capeau J, Magré J, Lascols O, Caron M, Béréziat V, Vigouroux C, Bastard JP. Capeau J, et al. Among authors: bereziat v. Biochem Soc Trans. 2005 Nov;33(Pt 5):1073-7. doi: 10.1042/BST0331073. Biochem Soc Trans. 2005. PMID: 16246048 Review.
[Primary lipodystrophies].
Capeau J, Magré J, Lascols O, Caron M, Béréziat V, Vigouroux C. Capeau J, et al. Among authors: bereziat v. Ann Endocrinol (Paris). 2007 Feb;68(1):10-20. doi: 10.1016/j.ando.2006.12.003. Epub 2007 Feb 21. Ann Endocrinol (Paris). 2007. PMID: 17320032 French.
Human lipodystrophies linked to mutations in A-type lamins and to HIV protease inhibitor therapy are both associated with prelamin A accumulation, oxidative stress and premature cellular senescence.
Caron M, Auclair M, Donadille B, Béréziat V, Guerci B, Laville M, Narbonne H, Bodemer C, Lascols O, Capeau J, Vigouroux C. Caron M, et al. Among authors: bereziat v. Cell Death Differ. 2007 Oct;14(10):1759-67. doi: 10.1038/sj.cdd.4402197. Epub 2007 Jul 6. Cell Death Differ. 2007. PMID: 17612587
Human lipodystrophies: genetic and acquired diseases of adipose tissue.
Capeau J, Magré J, Caron-Debarle M, Lagathu C, Antoine B, Béréziat VR, Lascols O, Bastard JP, Vigouroux C. Capeau J, et al. Endocr Dev. 2010;19:1-20. doi: 10.1159/000316893. Epub 2010 Jun 15. Endocr Dev. 2010. PMID: 20551664 Free PMC article. Review.
A homozygous mutation of prelamin-A preventing its farnesylation and maturation leads to a severe lipodystrophic phenotype: new insights into the pathogenicity of nonfarnesylated prelamin-A.
Le Dour C, Schneebeli S, Bakiri F, Darcel F, Jacquemont ML, Maubert MA, Auclair M, Jeziorowska D, Reznik Y, Béréziat V, Capeau J, Lascols O, Vigouroux C. Le Dour C, et al. Among authors: bereziat v. J Clin Endocrinol Metab. 2011 May;96(5):E856-62. doi: 10.1210/jc.2010-2234. Epub 2011 Feb 23. J Clin Endocrinol Metab. 2011. PMID: 21346069
39 results